{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:31:34Z","timestamp":1768267894535,"version":"3.49.0"},"reference-count":13,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Zentralbl Chir"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Mit der 3. Fassung erschien 2024 die \u00fcberarbeitete und aktualisierte S3-Leitlinie \u201eExokrines Pankreaskarzinom\u201c. In diesem Artikel geben wir einen \u00dcberblick \u00fcber die wichtigsten Neuerungen in Diagnostik und Therapie.<\/jats:p>","DOI":"10.1055\/a-2529-5372","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:15:41Z","timestamp":1744154141000},"page":"167-169","source":"Crossref","is-referenced-by-count":1,"title":["Leitlinien in K\u00fcrze Updates - Pankreas"],"prefix":"10.1055","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5296-6355","authenticated-orcid":false,"given":"Lennart","family":"von Fritsch","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Chirurgie, Universit\u00e4tsklinikum Schleswig-Holstein, Campus L\u00fcbeck, L\u00fcbeck, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Honselmann","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Chirurgie, Universit\u00e4tsklinikum Schleswig-Holstein, Campus L\u00fcbeck, L\u00fcbeck, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7651-6183","authenticated-orcid":false,"given":"Tobias","family":"Keck","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Chirurgie, Universit\u00e4tsklinikum Schleswig-Holstein, Campus L\u00fcbeck, L\u00fcbeck, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"ref3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejca.2018.09.007","article-title":"Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis","volume":"104","author":"A Lugo","year":"2018","journal-title":"Eur J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12916-016-0607-5","article-title":"Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium","volume":"14","author":"JM Ordonez-Mena","year":"2016","journal-title":"BMC Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jshs.2020.09.009","article-title":"Association between physical activity and digestive-system cancer: An updated systematic review and meta-analysis","volume":"10","author":"F Xie","year":"2021","journal-title":"J Sport Health Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/BF02925587","article-title":"The study of the mass screening of persons without symptoms and of the screening of outpatients with gastrointestinal complaints or icterus for pancreatic cancer in Japan, using CA19\u20139 and elastase-1 or ultrasonography","volume":"9","author":"T Homma","year":"1991","journal-title":"Int J Pancreatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1440-1746.2004.03219.x","article-title":"Clinical usefulness of carbohydrate antigen 19\u20139 as a screening test for pancreatic cancer in an asymptomatic population","volume":"19","author":"JE Kim","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.pan.2017.11.011","article-title":"International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017","volume":"18","author":"S Isaji","year":"2018","journal-title":"Pancreatology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000488372","article-title":"The Role of Staging Laparoscopy in Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis","volume":"36","author":"R Ta","year":"2019","journal-title":"Dig Surg"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"CD011490","DOI":"10.1002\/14651858.CD011490.pub2","article-title":"Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma","volume":"1","author":"RF Staerkle","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/S0140-6736(23)01366-1","article-title":"NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial","volume":"402","author":"ZA Wainberg","year":"2023","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa2208470","article-title":"Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer","volume":"388","author":"JH Strickler","year":"2023","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S2468-1253(23)00405-3","article-title":"Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial","volume":"9","author":"KJ Labori","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.esmogo.2023.07.001","article-title":"ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial","volume":"1","author":"J Lee","year":"2023","journal-title":"ESMO Gastrointestinal Oncology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"113950","DOI":"10.1016\/j.ejca.2024.113950","article-title":"A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for \u22653rd-line treatment of patients with advanced pancreatic adenocarcinoma","volume":"201","author":"T Enzler","year":"2024","journal-title":"Eur J Cancer"}],"container-title":["Zentralblatt f\u00fcr Chirurgie - Zeitschrift f\u00fcr Allgemeine, Viszeral-, Thorax- und Gef\u00e4\u00dfchirurgie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2529-5372.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:15:48Z","timestamp":1744154148000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2529-5372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":13,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2025,4,8]]},"published-print":{"date-parts":[[2025,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2529-5372","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0044-409X","1438-9592"],"issn-type":[{"value":"0044-409X","type":"print"},{"value":"1438-9592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}